Covid-19 Antibodies Found in Nonimmune Blood Cancer Patients After Receiving Booster

Weekly surveillance monitoring, also known as rapid cycle analysis, of more than 245,000 COVID-19 mRNA vaccine doses did not detect a safety signal for any outcome 21 days after vaccination.

In this episode, Peter Wehrwein, managing editor of Managed Healthcare Executive, speaks with Dr. Rodrigo Cerda. Dr. Cerda has been recently promoted to the position of senior vice president of health services and chief medical officer of Independence Blue Cross in Philadelphia. He is also a member of Managed Healthcare Executive’s editorial advisory board. Peter and Dr. Cerda discuss his new role at the Independence Blue Cross, what it means to be a chief medical officer at an insurer these days, valued-based care, social determinants of health, and, of course, the pandemic.

Paxlovid will continue to be accessible at no charge for adults and eligible children ages 12 to 18 who are not covered by the approval.

Briana Contreras, associate editor of MHE, spoke with Dr. Maria Hernandez, founder and CEO of Impact4Health. Maria shared not only how healthcare inequities remain to be an issue and what needs to be addressed, but also the progress that has been made over time through awareness, conversations and laws, especially due to the heightened awareness of inequities caused from the COVID-19 pandemic and the tragic deaths of George Floyd, Breonna Taylor and many more - which have now occurred over a year ago.

Results from a recent study published in JAMA Network displayed key thematic shifts and increases in language related to anxiety, anger, depression, and loneliness during the pandemic.

Researchers of a study examined the gender-specific COVID-19 case fatality risks among patients with a malignant neoplasm during hospital admissions as there is little data available for gender-specific COVID-19 mortality.